TDLP Transdel Pharmaceuticals, Inc. featured news, full reports, and detailed charts
Transdel Pharmaceuticals, Inc. (TDLP/TDLP.OB) Wrap Up:
Transdel Pharmaceuticals, Inc., a development stage specialty pharmaceutical company, focuses on the development and commercialization of non-invasive topically delivered medications in the United States. The company’s lead topical drug candidate, Ketotransdel, utilizes its proprietary Transdel cream formulation to facilitate the passage of ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), through the skin barrier to reach targeted underlying tissue where the drug exerts its localized anti-inflammatory and analgesic effect. The Ketotransdel, which has completed Phase 1/2 clinical study, is used for the treatment of acute pain and muscle soreness. It also investigates other drug can...Transdel Pharmaceuticals, Inc. (TDLP:OTC Bulletin Board Market)
Snapshot of Transdel Pharmaceuticals, Inc. (TDLP)
|
OPEN
--
|
PREVIOUS CLOSE
$1.60
|
|
|
DAY HIGH
--
|
DAY LOW
--
|
|
|
52 WEEK HIGH
10/6/09 - $4.00
|
52 WEEK LOW
12/18/08 - $0.55
|
|
|
MARKET CAP
25.0M
|
AVERAGE VOLUME 3 mo
4.0K
|
|
|
DILUTED EPS TTM
--
|
SHARES OUTSTANDING
15.7M
|
|
|
TDLP Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
TDLP Top Compensated Officers
Executives, Board Directors
Key developments for Transdel Pharmaceuticals, Inc. (TDLP)
To present a company overview
To present overview of the company
Transdel Pharmaceuticals Inc. announced the appointment of industry veteran Joachim P.H. Schupp, MD as Chief Medical Officer. Dr. Schupp has almost 25 years of leadership experience in the pharmaceutical industry. He has achieved the professional distinction of international project teams that have brought several drugs through the development and the regulatory process and on to the market globally. Dr. Schupp spent 19 years with Novartis Pharmaceuticals in Switzerland where he held various positions in clinical development and global project management. Most recently, Dr. Schupp has worked as an Executive Consultant for pharmaceutical and biotechnology companies.
TDLP Competitors
| Company | Last | Change | |
| No competitor information is available for TDLP. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | TDLP | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | 12.8x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | -- | Not Meaningful |
|
TDLP |
||
TDLP transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||